Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Lung Neoplasms 6Neoplasms 4Colonic Neoplasms 3Prostatic Neoplasms 2Patient Satisfaction 2Ovarian Neoplasms 2Breast Neoplasms 2Brain Neoplasms 2Urinary Bladder Neoplasms 1Tuberculosis, Pulmonary 1Thoracic Diseases 1Supratentorial Neoplasms 1Stomach Ulcer 1Stomach Neoplasms 1Recurrence 1Rectal Neoplasms 1Polyps 1Pituitary Neoplasms 1Pain, Postoperative 1Pain 1Overweight 1Obesity 1Neurofibromatoses 1Neoplastic Cells, Circulating 1Neoplasm Metastasis 1Mouth Neoplasms 1Melanoma 1Liver Neoplasms 1Kidney Neoplasms 1Hypoxia 1

Interventions

lorlatinib 1elemene 1capmatinib 1aumolertinib 1aflutinib 1Technetium Tc 99m Aggregated Albumin 1Sunitinib 1Sevoflurane 1Radiotherapy 1Propofol 1Gefitinib 1Fluorouracil 1Craniotomy 1Carboplatin 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Carcinoma × Propofol × Clear all
NCT04475705 2022-03-16

Propofol vs Sevo for Paediatric Tumor Surgery

Hong Kong Children's Hospital

Phase 4 Recruiting
100 enrolled

Carcinoma, Neoplastic Cells, Circulating, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡